Pfreundschuh, M G <br/><br/>
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.  [electronic resource] 

 -  Cancer treatment reports  Dec 1987 
 - 1203-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dacarbazine--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance<br/>Etoposide--administration & dosage<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lomustine--administration & dosage<br/>Middle Aged<br/>Multi-Institutional Systems<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Vinblastine<br/>Vincristine--administration & dosage<br/>Vindesine--administration & dosage